Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
J Clin Oncol 2020 Dec 04
Lessons From ADAURA on Adjuvant Cancer Drug Trials: Evidence, Ethics, and Economics.
Related Questions
Should 3 years of adjuvant osimertinib be the standard of care for resected Stage IB-IIIA EGFRm NSCLC?
7245
×
To continue please login or register
Register
or
Sign in
